157 related articles for article (PubMed ID: 6762661)
1. Augmentin: laboratory studies.
Farrell ID; Turner PJ
Scott Med J; 1982; 27 Spec No.():S21-3. PubMed ID: 6762661
[TBL] [Abstract][Full Text] [Related]
2. The history and background of Augmentin.
Rolinson GN
S Afr Med J; 1982 Jul; 62(5 Spec No):3A-4A. PubMed ID: 6979804
[TBL] [Abstract][Full Text] [Related]
3. In vitro evaluation of Augmentin by broth microdilution and disk diffusion susceptibility testing: regression analysis, tentative interpretive criteria, and quality control limits.
Fuchs PC; Barry AL; Thornsberry C; Gavan TL; Jones RN
Antimicrob Agents Chemother; 1983 Jul; 24(1):31-8. PubMed ID: 6625554
[TBL] [Abstract][Full Text] [Related]
4. [Activity of the amoxicillin-clavulanic acid (augmentin) combination on strains of hospital isolates].
Deforges L; Le Van Thoi J; Soussy CJ; Duval J
Pathol Biol (Paris); 1985 May; 33(5):301-8. PubMed ID: 3929215
[TBL] [Abstract][Full Text] [Related]
5. [Urinary tract infections in children. Status in a pediatric hospital and sensitivity of bacterial strains to amoxycillin-clavulanic acid combination].
Cochat N; Barbe G; Boutin-Tranchant ME; Cochat P
Pediatrie; 1987; 42(4):309-14. PubMed ID: 3671031
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of augmentin against pathogenic bacteria and its comparison with other antibiotics.
Perryman F; Johnson S; Qadri SM
Chemotherapy; 1983; 29(2):111-5. PubMed ID: 6839863
[TBL] [Abstract][Full Text] [Related]
7. Antibacterial activities of amoxicillin alone and in combination with clavulanic acid correlated with beta-lactamase production.
Hsu LY; Chang SC; Luh KT; Hsieh WC
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1991 Aug; 24(3):272-80. PubMed ID: 1818798
[TBL] [Abstract][Full Text] [Related]
8. In vitro antibacterial activities of ticarcillin alone and ticarcillin plus clavulanic acid against beta-lactamase producing and non-producing microorganisms.
Hsueh PR; Chang SC; Chen YC; Hsu LY; Luh KT; Hsieh WC
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1992 Aug; 25(3):149-59. PubMed ID: 1342000
[TBL] [Abstract][Full Text] [Related]
9. Combined antibacterial activity of amoxicillin with clavulanic acid against ampicillin-resistant strains.
Matsuura M; Nakazawa H; Hashimoto T; Mitsuhashi S
Antimicrob Agents Chemother; 1980 Jun; 17(6):908-11. PubMed ID: 6967713
[TBL] [Abstract][Full Text] [Related]
10. Phenomenon of resistance to Augmentin associated with sensitivity to ampicillin: occurrence and explanation.
Brumfitt W; Hamilton-Miller JM; Dixson S; Gargan RA; Gooding A
J Clin Pathol; 1983 Jun; 36(6):670-3. PubMed ID: 6343436
[TBL] [Abstract][Full Text] [Related]
11. The in vitro activity of amoxycillin with clavulanic acid against clinically significant bacteria. A multicentre study.
Van den Ende J; Gricius ME; De Klerk HC; Neiteler BF; Forder AA; Venter L; Hallett AF; Koornhof HJ; Robinson R; Van Rensburg AJ; Lindeque KP
S Afr Med J; 1982 Jul; 62(5 Spec No):5A-8A. PubMed ID: 6979805
[TBL] [Abstract][Full Text] [Related]
12. Implications of beta-lactamase-inhibitor combinations.
Fuchs PC; Barry AL
J Reprod Med; 1990 Mar; 35(3 Suppl):317-21. PubMed ID: 2319514
[TBL] [Abstract][Full Text] [Related]
13. [Combined antibacterial activity of clavulanic acid with amoxicillin and ampicillin against Gram-negative strains].
Mascellino MT; Prignano G; Lorenzi A; Iegri F; Martorano E; Catania S; Ginanni Corradini S
Boll Ist Sieroter Milan; 1984; 63(5):447-52. PubMed ID: 6335660
[TBL] [Abstract][Full Text] [Related]
14. In vitro efficacy of augmentin in beta-lactamase producing bacteria.
Agrawal SK; Goel MM; Misra AB
Indian J Med Res; 1987 Sep; 86():298-300. PubMed ID: 3501408
[No Abstract] [Full Text] [Related]
15. [A comparison of the in vitro susceptibility of three bacteria to beta-lactamase inhibitors and to ampicillin and cefazolin].
Acar N; Diri MC; Türkyilmaz FR
Mikrobiyol Bul; 1987 Oct; 21(4):284-8. PubMed ID: 3332705
[TBL] [Abstract][Full Text] [Related]
16. Comparative in vitro activity of amoxycillin/clavulanate (augmentin), ceftazidime and ceftriaxone against hospital strains of gram-negative and -positive bacteria.
Abd-Elalim Eltahawy AT; Khalaf RM
Chemioterapia; 1988 Apr; 7(2):75-8. PubMed ID: 3293818
[TBL] [Abstract][Full Text] [Related]
17. Activity of amoxycillin/clavulanate against beta-lactamase-producing Escherichia coli and Klebsiella spp.
Roy C; Segura C; Torrellas A; Reig R; Teruel D; Hermida M
J Antimicrob Chemother; 1989 Nov; 24 Suppl B():41-7. PubMed ID: 2691485
[TBL] [Abstract][Full Text] [Related]
18. In vitro-activity of clavulanic acid and amoxicillin combined against amoxicillin-resistant bacteria.
Peters G; Pulverer G; Neugebauer M
Infection; 1980; 8(3):104-6. PubMed ID: 6903180
[TBL] [Abstract][Full Text] [Related]
19. Divergent disk susceptibility of coagulase-negative staphylococci to penicillinase-resistant penicillins and augmentin (amoxycillin/clavulanic acid).
Traub WH
Chemotherapy; 1985; 31(2):119-23. PubMed ID: 3872778
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
